ASX Announcement 18 November 2026 Proposed Merger with Genetic Signatures Limited not proceeding Microba Life Sciences Limited (ASX: MAP) (“Microba” or “the Company”) refers to previous announcements relating to the proposed merger between Genetic Signatures Limited (ASX: GSS) (GSS) and...
MAP: Proposed Merger with GSS not proceeding
Filed with ASX · · 1 page · English
Summary by 6ix AI
Microba is currently exploring funding options while in voluntary suspension of trading. This outcome is disappointing after months of discussions and due diligence regarding the merger.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Microba Life Sciences Limited on 6ix
Story so far
Earlier from Microba Life Sciences
- GSS: End of Proposed Merger with Microba Life Sciences
- Suspension from Quotation
- TOV: GSS - Panel Receives Application
- Trading Halt Request
- Trading Halt
Later from Microba Life Sciences
All Microba Life Sciences news releasesFollow Microba Life Sciences into a list and get an email when it puts out news.
Follow Microba Life Sciences